GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » EV-to-Revenue

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) EV-to-Revenue : 0.92 (As of May. 25, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sihuan Pharmaceutical Holdings Group's enterprise value is $239.6 Mil. Sihuan Pharmaceutical Holdings Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $260.1 Mil. Therefore, Sihuan Pharmaceutical Holdings Group's EV-to-Revenue for today is 0.92.

The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's EV-to-Revenue or its related term are showing as below:

SHPHF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.44   Med: 3.9   Max: 18.78
Current: 0.92

During the past 13 years, the highest EV-to-Revenue of Sihuan Pharmaceutical Holdings Group was 18.78. The lowest was 0.44. And the median was 3.90.

SHPHF's EV-to-Revenue is ranked better than
81.45% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs SHPHF: 0.92

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Sihuan Pharmaceutical Holdings Group's stock price is $0.065. Sihuan Pharmaceutical Holdings Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.03. Therefore, Sihuan Pharmaceutical Holdings Group's PS Ratio for today is 2.32.


Sihuan Pharmaceutical Holdings Group EV-to-Revenue Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group EV-to-Revenue Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 1.30 2.45 2.37 1.63

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 - 2.37 - 1.63

Competitive Comparison of Sihuan Pharmaceutical Holdings Group's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sihuan Pharmaceutical Holdings Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's EV-to-Revenue falls into.



Sihuan Pharmaceutical Holdings Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sihuan Pharmaceutical Holdings Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=239.570/260.135
=0.92

Sihuan Pharmaceutical Holdings Group's current Enterprise Value is $239.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sihuan Pharmaceutical Holdings Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $260.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sihuan Pharmaceutical Holdings Group  (OTCPK:SHPHF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sihuan Pharmaceutical Holdings Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.065/0.028
=2.32

Sihuan Pharmaceutical Holdings Group's share price for today is $0.065.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sihuan Pharmaceutical Holdings Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Business Description

Traded in Other Exchanges
Address
Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.